secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001193125-22-298052
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm raises $165M in PIPE; sells 31.8M shares at $5.19 with warrants
--------------------------------------------------------------------------

- Gross proceeds ~$165M from sale of 31,791,908 shares at $5.19 and warrants for 9,537,563 shares at $6.36.
- Lead investors include Avidity Partners, Adage Capital, Armistice Capital, and others; expected close Dec 7, 2022.
- Proceeds to fund selinexor and eltanexor clinical programs, working capital; cash runway extended into late 2025.
- Warrants exercisable for five years after closing; registration statement for resale to be filed within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312522298052/0001193125-22-298052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312522298052/d418804d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-298052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer